Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo

Science. 1981 Jan 30;211(4481):487-9. doi: 10.1126/science.7455688.

Abstract

Growth of mouse lymphoma L5178Y, which contains large quantitites of the gangliotriosylceramide (GgOs3Cer), in DBA/2 mice was suppressed by passive immunization with monoclonal immunoglobulin G3 antibodies to GgOS3Cer, but not by immunoglobulin M antibodies with or without added complement. Most groups of mice treated with monoclonal immunoglobulin G3 antibodies did not develop tumors, but the tumor that appeared in a treated animal had a much lower amount of the GgOS3Cer than the cells used for inoculation. Thus, passive immunization either prevented growth of the lymphoma or caused selection of a variant with a lower quantity of the antigen GgOS3Cer.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, Neoplasm
  • Antigens, Surface
  • Clone Cells / immunology
  • Glycolipids / immunology*
  • Hybrid Cells / immunology
  • Immunization, Passive
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin M / administration & dosage
  • Immunotherapy
  • Lymphoma / immunology
  • Lymphoma / therapy*
  • Mice
  • Neoplasms, Experimental / therapy

Substances

  • Antigens, Neoplasm
  • Antigens, Surface
  • Glycolipids
  • Immunoglobulin G
  • Immunoglobulin M